Pharmacopeia
CWP-0061
CLARITHROMYCIN
Anti-infectives · Anti-infectives · Level 3
Core pharmacology
- Class Group
ANTIBIOTIC:
MACROLIDE- Legacy Cicm Level
Level 3
- Presentation
PO, IV
- Mechanism of action
Inhibits 50s subunit to prevent protein synthesis
Bacteriocidal/static- Antimicrobial Spectrum
1. Gram positives (better strep and listeria cover)
2. Anaerobes
3. Obligate intracellular organisms (legionella, mycoplasma)
4. Gram negatives- including Helicobacter- Adverse Effects Toxicity
1. Nausea, vomiting, diarrhea
2. Hypersensitivity
3. QT prolongation and increased risk of torsade’s
4. Inhibits CYP3A4 (increased warfarin, carbamazepine, ciclosporin, valproate, tacrolimus, digoxin)
Inhibits P-glycoprotein- Absorption
50% absorption
- Distribution
Poor CSF penetration but good lung penetration
- Protein binding
8% PB
- Metabolism
Hepatic metabolism via N-dealkalylation
- Excretion
Renally excreted (33% unchanged)
10% in bile- Half-life
T1/2= 5-6 hours